News Room

Following the decision by District Judge Leonie Brinkema finding that Google illegally monopolized segments of the ad space, ITIF released the following statement from Joseph V. Coniglio.

ITIF urged FCC Chairman Carr to reject President Trump’s call to take away CBS's broadcast license, warning that content-based licensing actions violate First Amendment protections and risk politicizing the Commission.

Small modular reactors are the only scalable path to U.S. nuclear leadership—and without bold policy action now, China and Russia will seize the advantage.

Following President Trump’s executive order ending the de minimis loophole, ITIF released the following statement from Policy Analyst Eli Clemens.

Chinese e-commerce platforms like SHEIN and Temu are rapidly capturing market share from U.S. e-commerce leaders, driven by a state-backed strategy to expand China’s global influence, financial footprint, and ability to compete in artificial intelligence, according to a new ITIF report.

Today's Supreme Court hearing underscores the urgent need for Congress to reform the Universal Service Fund to ensure broadband subsidies effectively address the digital divide, says ITIF.

The model of globalization that U.S. policymakers have advanced throughout the postwar era has failed, but the current push toward the opposite extreme of protectionist autarky cannot be its long-term replacement. A new report by ITIF outlines a strategic framework for “Globalization 2.0.”

Statement from Joseph V. Coniglio following the EU’s DMA decisions specifying Apple’s interoperability requirements and preliminary findings that Google failed to comply with the DMA’s self-preferencing and anti-steering obligations.

Tariffs on Canada and Mexico? A costly mistake that will hurt U.S. consumers, disrupt supply chains, and strain key alliances, says Stephen Ezell, vice president of global innovation policy at ITIF.

The Biden-era Inflation Reduction Act (IRA) undermines incentives to produce new innovations in small-molecule drugs and therefore could slow advances to treat diseases and conditions ranging from high blood pressure to Parkinson’s, according to a new ITIF report.

Boston Globe mentioned Sandra Barbosu 2024 report on the U.S. biopharma industry in a story on America’s biotech sector slipping away.

Time.News quoted Rob Atkinson in a story on the impacts of Trump’s tariffs on U.S.-China trade relations.

Kyiv Post cited Megan Ostertag in an opinion piece about Trump’s trade concerns with China and China pushing back.

ArsTechnica cited Lawrence Zhang in an article about how much taxes U.S. streaming services should pay internationally.

TechTarget covered Joeseph Coniglio's event on the landmark DOJ v. Google case moving to a high-stakes remedies trail.

TechTarget quoted Stephen Ezell in a story on Trump tasking the new U.S. Investment Accelerator Office with managing the CHIPS Program Office and reducing businesses' regulatory burdens.

Taipei Times quoted Stephen Ezell in an article on Taiwan’s decision not to retaliate against Trump’s tariffs on Taiwanese goods.

Stephen Ezell joined Yahoo! Finance to discuss the Trump Administration’s exemptions for biopharma products, while arguing the ripple effects of tariffs will be felt regardless.

The New York Times quoted Robert Atkinson in coverage of possible explanations to the Trump Administration’s tariff obsession.

The Independent cited ITIF’s Can China Innovate series, noting the lack of urgency US policymakers are operating with in regards to competition with China in advanced industries.